Cogent Biosciences, Inc. ($COGT)
Filing Information
| Accession Number | 0001104659-26-038057 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 1, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
14,028,000
Total Value
$242,620,000.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Mar 31, 2026 | Conversion | 7,000,000 | โ | โ | 12,503,418 | Indirect | Fairmount Healthcare Fund II LP | View Details | |
Director | Common Stock | โ | Mar 31, 2026 | Sale | 7,000,000 | $34.66 | $242,620,000.00 | 5,503,418 | Indirect | Fairmount Healthcare Fund II LP | View Details | |
Director | Series A Convertible Preferred Stock | Derivative | Mar 31, 2026 | Conversion | 28,000 | $0.00 | $0.00 | 39,414 | Indirect | Fairmount Healthcare Fund II LP | View Details |